PDPN and lung adenocarcinoma: Increased podoplanin expression in CAFs and a positive correlation between CAF podoplanin expression and poor prognosis were demonstrated in lung adenocarcinoma, the invasive ductal carcinoma of breast and pancreas, and melanoma [67,68].